Accelerate biomedical innovations. Together.

Too many promising medical innovations never reach the patient due to ever more stringent and difficult landscape of medical devices and cell therapy (GMP), legislation and technical validation.

Medace is committed to bring your innovative (bio)medical concepts to the market and patients faster.

More about Medace

What’s in it for you?

ISO certified quality management system

Access to state of the art specialized infrastructure

Validated equipment

Technical knowhow

ISO and GMP expertise

Dedicated training program by in-house professionals

What do we offer?

We offer a work-learning environment that allows you to develop your technical product dossier needed for clinical validation. At the same time we guide you in how to produce your product according to the ISO and GMP standards.

Download brochureBuild your package

With a broad range of training, expertise and support we provide everything you need to know about regulatory, quality assurance, technical development and so much more. We guide you through the set up and development of technical files. Quality is guaranteed as everything is covered under our overarching ISO certificate.

From flexible office spaces to R&D labs and specialized cleanrooms with validated equipment, a full Quality Management system and trained personnel, at Medace you find everything to develop and manufacture your clinical grade product.

Let’s meet!

Interested to join our community? Got some questions you want answered? Thinking of creating your own space at Medace?

Plan your meeting with CBO Kurt Gielen now.

Let's meet

News and resources

Professor Akhondi, founder of InoCells and Kurt Gielen, CBO Medace signing the collaborationNews
14 August 2020

InoCells joins Medace to bring stem cell therapy for infertility to patients

August 2020 - InoCells to set up ATMP Manufacturing at Medace   The Dutch start-up company InoCells has developed a unique stem cell therapy to rejuvenate the ovary of infertile…
Stem Cells coverKnowledgeNews
21 July 2020

Publication: Improving patient outcomes with regenerative medicine

Chief Business Officer of Medace Kurt Gielen recently wrote this interesting perspective article together with Joshua Hunsberger and several co-authors, now published at Stem Cells Translational Medicine:  Kurt Gielen: I'd like to…
Annemie Schols-MedaceNews
15 July 2020

Medace welcomes new dean Faculty Health Medicine and Life Sciences: Prof. Dr. Annemie Schols

Last week we welcomed Prof. Dr. Annemie Schols, the new dean of the Faculty of Health, Medicine and Life Sciences (FHML), at our Medace facilities. In alignment with the objectives…
See all news and resources